Second hypertension drug recalled due to contamination

Second hypertension drug recalled due to contamination
(HealthDay)—Another hypertension drug is being recalled due to contamination that could pose a cancer risk, the U.S. Food and Drug Administration says.

Certain lots of irbesartan are being recalled by SciGen because they contain an industrial chemical that is a suspected carcinogen, CNN reported. The recalled drugs have "Westminster Pharmaceuticals" and "GSMS Inc." on the label.

Another heart drug, valsartan, was recalled recently due to contamination with possible cancer-causing chemicals, CNN reported.

Not all medicines that contain valsartan or irbesartan are being recalled. The new recall covers only about 1 percent of irbesartan drug products available in the United States, according to the FDA.


Explore further

FDA recalls heart medication valsartan, citing cancer concerns

More information: CNN Article
FDA Recall Alert

Copyright © 2018 HealthDay. All rights reserved.

Citation: Second hypertension drug recalled due to contamination (2018, November 2) retrieved 20 June 2019 from https://medicalxpress.com/news/2018-11-hypertension-drug-recalled-due-contamination.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
3 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more